VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IEXIDEX Corporation
$227.19$16.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIEXFinancials

IDEX Corporation (IEX) Financials

30Y historyFree accessUpdated daily

Revenue growth remains sensitive to end-market cycles, fluctuating from a 5.3% contraction in 2024Q1 to a 10.1% expansion by 2025Q3, while operating margins have struggled to surpass the 22% threshold.

IEX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue3.53B3.46B3.27B3.27B3.18B2.76B2.35B2.49B2.48B2.29B2.11B2.02B2.15B2.02B1.95B1.84B1.51B1.33B1.49B1.36B1.15B1.04B928.3M797.92M742.01M726.95M704.28M655M640.1M552.2M562.6M
Revenue Growth %7.54%5.77%-0.16%2.89%15.09%17.57%-5.73%0.44%8.58%8.25%4.57%-5.92%6.11%3.58%6.3%21.5%13.79%-10.73%9.63%17.64%10.7%12.39%16.34%7.53%2.07%3.22%7.52%2.33%15.92%-1.85%15.45%
Cost of Goods Sold1.96B1.92B1.75B1.65B1.59B1.4B1.19B1.22B1.32B1.22B1.13B1.08B1.16B1.12B1.11B1.05B862.79M777.67M862.54M762.08M652.73M573.49M536.26M488.6M460.58M463.23M401.42M375.1M364.5M313.1M329.5M
COGS % of Revenue-55.49%53.6%50.43%49.89%50.76%50.76%48.94%53.06%53.26%53.39%53.42%54.03%55.13%57.01%56.95%57.02%58.49%57.91%56.09%56.52%54.97%57.77%61.23%62.07%63.72%57%57.27%56.94%56.7%58.57%
Gross Profit1.57B1.54B1.52B1.62B1.59B1.36B1.16B1.27B1.17B1.07B984.87M941.32M987.41M908.16M840.1M791.35M650.16M551.09M626.95M596.55M502.21M437.77M392.04M309.32M281.44M263.72M302.86M279.9M275.6M239.1M233.1M
Gross Margin %44.42%44.51%46.4%49.57%50.11%49.24%49.24%51.06%46.94%46.74%46.61%46.58%45.97%44.87%42.99%43.04%42.97%41.45%42.09%43.91%43.48%41.96%42.23%38.77%37.93%36.28%43%42.73%43.06%43.3%41.43%
Gross Profit Growth %-1.46%-6.54%1.78%17.11%17.58%-9.1%9.26%9.06%8.55%4.63%-4.67%8.73%8.1%6.16%21.72%17.98%-12.1%5.1%18.79%14.72%11.66%26.74%9.91%6.72%-12.92%8.2%1.56%15.27%2.57%16.09%
Operating Expenses833.6M818.8M819.8M872.1M804.9M707.5M621.13M672.09M581.72M566.04M533.69M510.41M539.52M509.45M480.89M451.9M390.07M355.05M372.89M341.47M285M256.74M242.65M199.46M181.27M179.06M186.34M175.3M166.1M135.5M134.7M
OpEx % of Revenue-23.68%25.08%26.64%25.3%25.59%26.41%26.94%23.42%24.75%25.26%25.26%25.12%25.17%24.61%24.58%25.78%26.7%25.04%25.13%24.68%24.61%26.14%25%24.43%24.63%26.46%26.76%25.95%24.54%23.94%
Selling, General & Admin826.1M818.8M749M696.2M648.1M573.2M490.63M523.29M533.72M523.64M494.29M476.81M502.72M476.45M444.49M415.9M358.27M325.45M343.39M313.37M260.2M232.94M221.41M199.46M181.27M164.89M149.64M140.5M132.6M110.6M111.5M
SG&A % of Revenue-23.68%22.91%21.27%20.37%20.73%20.86%20.98%21.49%22.89%23.39%23.6%23.41%23.54%22.74%22.62%23.68%24.48%23.05%23.06%22.53%22.33%23.85%25%24.43%22.68%21.25%21.45%20.72%20.03%19.82%
Research & Development00178.6M175.9M156.8M133M130.5M148.8M48M42.4M39.4M33.6M36.8M33M36.4M36M31.8M29.6M29.5M28.1M24.8M23.8M21.24M00000000
R&D % of Revenue--5.46%5.37%4.93%4.81%5.55%5.96%1.93%1.85%1.86%1.66%1.71%1.63%1.86%1.96%2.1%2.23%1.98%2.07%2.15%2.28%2.29%--------
Other Operating Expenses1.1M0-107.8M001.3M000000000000000000014.16M36.7M34.8M33.5M24.9M23.2M
Operating Income734.4M720M696.9M750.7M789.5M654M536.79M601.75M584.17M503.04M451.17M430.91M447.9M398.71M359.21M339.44M260.08M196.03M254.06M255.08M217.21M181.03M149.38M109.86M100.37M73.44M116.52M104.6M109.5M103.6M98.4M
Operating Margin %20.8%20.82%21.32%22.93%24.81%23.65%22.83%24.12%23.52%21.99%21.35%21.32%20.85%19.7%18.38%18.46%17.19%14.74%17.06%18.77%18.81%17.35%16.09%13.77%13.53%10.1%16.54%15.97%17.11%18.76%17.49%
Operating Income Growth %-3.31%-7.17%-4.91%20.72%21.84%-10.79%3.01%16.13%11.5%4.7%-3.79%12.34%11%5.82%30.51%32.67%-22.84%-0.4%17.44%19.98%21.19%35.97%9.45%36.68%-36.97%11.39%-4.47%5.7%5.28%14.15%
EBITDA944.7M926.5M872.5M902.8M909.2M757M620.28M678.62M661.72M587.25M538.07M509.03M524.8M478.05M437.52M411.83M318.19M252.38M302.66M293.58M247.62M211.68M180.91M139.92M130.48M117.73M153.22M139.4M143M128.5M121.6M
EBITDA Margin %26.76%26.8%26.69%27.58%28.57%27.38%26.38%27.2%26.64%25.67%25.46%25.19%24.43%23.62%22.39%22.4%21.03%18.98%20.32%21.61%21.44%20.29%19.49%17.54%17.58%16.2%21.76%21.28%22.34%23.27%21.61%
EBITDA Growth %7.57%6.19%-3.36%-0.7%20.11%22.04%-8.6%2.56%12.68%9.14%5.7%-3.01%9.78%9.26%6.24%29.43%26.08%-16.61%3.09%18.56%16.98%17.01%29.3%7.23%10.82%-23.16%9.91%-2.52%11.28%5.67%17.72%
D&A (Non-Cash Add-back)210.3M206.5M175.6M152.1M119.7M103M83.5M76.88M77.54M84.22M86.89M78.12M76.91M79.33M78.31M72.39M58.11M56.35M48.6M38.5M30.41M30.65M31.53M30.05M30.11M44.3M36.7M34.8M33.5M24.9M23.2M
EBIT728.8M697M683.8M812M790.1M617.5M521.11M570.92M579.55M506.82M420.98M426.95M427.11M387.9M120.82M297.02M239.22M177.89M211.43M258.52M218.25M181.59M148.64M109.86M100.17M84.66M116.52M104.6M109.5M103.6M87.7M
Net Interest Income-64.3M-64.4M-44.5M-51.7M-40.7M-37.7M-50.77M-38.01M-50.61M-51.54M-52.47M-34.61M-34.67M-34.78M-34.61M-23.14M-7.34M-9.07M-19.2M-23.35M-16.35M-14.37M-14.76M00000000
Interest Income0000000000000000000000000000000
Interest Expense64.3M64.4M44.5M51.7M40.7M37.7M50.77M38.01M50.61M51.54M52.47M34.61M34.67M34.78M34.61M23.14M7.34M9.07M19.2M23.35M16.35M14.37M14.76M00000000
Other Income/Expense-69.3M-87.4M-57.6M9.6M-40.1M-74.2M-66.45M-68.84M-55.23M-47.77M-82.66M-38.56M-55.46M-45.58M-273.01M-65.56M-28.21M-27.21M-61.83M-19.92M-15.31M-13.81M-15.51M-13.19M-16.48M-20.01M-15.49M-17.4M-21.8M-19.1M-8.8M
Pretax Income665.1M632.6M639.3M760.3M749.4M579.8M470.34M532.9M528.94M455.27M368.51M392.35M392.44M353.13M86.2M273.88M231.87M168.83M198.7M235.16M201.89M168.93M133.88M96.67M83.89M53.43M101.03M87.2M87.7M84.5M78.9M
Pretax Margin %18.84%18.3%19.56%23.22%23.55%20.97%20%21.36%21.3%19.9%17.44%19.42%18.27%17.45%4.41%14.9%15.32%12.7%13.34%17.31%17.48%16.19%14.42%12.12%11.31%7.35%14.34%13.31%13.7%15.3%14.02%
Income Tax158.1M150.1M134.7M164.7M162.7M130.5M92.56M107.38M118.37M118.02M97.4M109.54M113.05M97.91M48.57M80.02M74.77M55.44M67.34M79.3M68.17M59.13M47.47M34.32M29.78M20.72M37.58M32.8M33.3M31M28.7M
Effective Tax Rate %23.77%23.73%21.07%21.66%21.71%22.51%19.68%20.15%22.38%25.92%26.43%27.92%28.81%27.73%56.35%29.22%32.25%32.84%33.89%33.72%33.77%35%35.46%35.5%35.5%38.78%37.2%37.61%37.97%36.69%36.38%
Net Income507.7M483.2M505M596.1M586.9M449.4M377.8M425.52M410.57M337.26M271.11M282.81M279.39M255.22M37.63M193.86M157.1M113.39M131.36M155.15M146.67M109.8M86.41M62.35M54.11M32.71M63.45M54.4M64.6M58.7M50.2M
Net Margin %14.38%13.98%15.45%18.21%18.45%16.25%16.07%17.06%16.53%14.74%12.83%14%13.01%12.61%1.93%10.54%10.38%8.53%8.82%11.42%12.7%10.52%9.31%7.81%7.29%4.5%9.01%8.31%10.09%10.63%8.92%
Net Income Growth %5.97%-4.32%-15.28%1.57%30.6%18.95%-11.21%3.64%21.74%24.4%-4.14%1.22%9.47%578.22%-80.59%23.4%38.55%-13.68%-15.33%5.78%33.58%27.08%38.58%15.23%65.43%-48.44%16.63%-15.79%10.05%16.93%10.82%
Net Income (Continuing)507M482.5M504.6M595.6M586.7M449.3M377.78M425.52M410.57M337.26M271.11M282.81M279.39M255.22M37.63M193.86M157.1M113.39M127.03M155.86M133.72M108.58M86.41M62.35M54.11M32.71M63.45M54.4M54.4M53.5M44.4M
Discontinued Operations0000000000000000000001.23M000000000
Minority Interest-1.4M-1.3M-600K-200K300K0123K000000000000000000000000
EPS (Diluted)6.826.416.647.857.725.884.945.575.294.363.533.623.453.090.452.321.901.401.531.891.811.391.120.830.740.470.920.800.920.870.75
EPS Growth %7.13%-3.46%-15.41%1.68%31.29%19.03%-11.31%5.29%21.33%23.51%-2.49%4.93%11.65%586.67%-80.6%22.11%35.71%-8.5%-19.05%4.42%30.22%24.11%34.94%12.16%57.45%-48.91%15%-13.04%5.75%16%10.29%
EPS (Basic)-6.416.677.887.755.914.995.635.374.413.573.653.483.110.452.341.931.411.551.921.841.431.150.850.760.480.950.820.940.890.77
Diluted Shares Outstanding74.4M75.3M75.9M75.9M76M76.4M76.4M76.45M77.56M77.33M76.76M77.97M80.73M82.49M83.64M83.54M81.98M80.73M82.32M82.09M80.98M79.08M77.02M74.96M73.09M69.86M68.92M67.69M67.62M67.66M66.77M
Basic Shares Outstanding74.3M75.3M75.7M75.6M75.7M76M75.74M75.59M76.41M76.23M75.8M77.13M79.72M81.52M82.69M82.14M80.47M79.72M81.12M80.67M79.53M77.09M75.11M73.19M71.26M68M66.88M66.47M66M65.64M64.85M
Dividend Payout Ratio-44%40.65%31.99%30.23%35.85%40.18%34.59%31.05%32.96%37.86%34.01%30.68%28.57%170.31%28.17%29.49%34.07%29.99%24.02%20.72%22.48%24.78%29.32%32.75%52.16%26.45%30.33%24.46%23.85%24.5%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Bioprocessing demand volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Exhibits Cyclical Variability

According to recent quarterly filings, IDEX's revenue growth has fluctuated significantly, ranging from a 5.3% contraction in 2024Q1 to a 10.1% expansion by 2025Q3, suggesting that the company's top-line performance remains sensitive to the specific industrial and life science end-market cycles it serves.

The inconsistent revenue trajectory appears to reflect the company's reliance on both transactional component sales and longer-cycle project-based orders. Investors should monitor whether the recent growth recovery is sustainable or merely a reflection of easier year-over-year comparisons in the Fluid & Metering Technologies segment.

Structural Margin Resilience Amid Fluctuations

As reported in financial statements, IDEX has maintained a structural gross margin profile hovering near 44%, demonstrating consistent pricing power despite the 2024Q4 dip to 38.8% which likely stemmed from temporary cost pressures or shifts in the product mix within its specialized industrial segments.

The ability to sustain mid-40s gross margins suggests that the company's 'high-mix, low-volume' engineering strategy effectively insulates it from the commoditization seen in broader industrial peers. However, the volatility in quarterly operating margins warrants investigation into whether the 80/20 efficiency program is reaching a point of diminishing returns.

Earnings Quality Impacted by SBC

Based on reported figures, IDEX's net income has faced periodic pressure from stock-based compensation, which reached $15.8 million in 2026Q1, potentially masking the underlying operational performance and creating a divergence between GAAP earnings and the company's core cash-generating capabilities during certain reporting periods.

The variability in EPS growth, which swung from a 42.9% decline in 2024Q3 to a 27.8% increase in 2026Q1, suggests that investors should focus on organic growth metrics rather than headline GAAP figures. The recurring nature of restructuring charges associated with the 80/20 model further complicates the assessment of true normalized profitability.

Efficiency Gains May Be Exhausted

While IDEX has historically leveraged its 80/20 operational model to drive margin expansion, the recent stagnation in operating margins suggests that the low-hanging fruit of operational pruning may be exhausted, leaving the company vulnerable to margin compression if organic growth fails to offset rising input costs.

Short-term margin volatility may indicate that the company is struggling to pass through inflationary pressures as effectively as in previous cycles. If the HST segment's growth continues to decelerate, the company may find it difficult to maintain its current valuation premium relative to less specialized industrial conglomerates.

IEX — Frequently Asked Questions

Quick answers to the most common questions about buying IEX stock.

What was IDEX Corporation's (IEX) revenue in 2025?

For fiscal year 2025, IDEX Corporation (IEX) reported total revenue of $3.46B. This represents a 514.6% increase compared to $562.6M in 1996.

Is IDEX Corporation (IEX) profitable?

IDEX Corporation (IEX) is profitable, generating $483.2M in net income for the fiscal year ending 2025 with a net profit margin of 14.0%.

What is IDEX Corporation's operating profit margin?

IDEX Corporation (IEX) reported an operating income of $720.0M, resulting in an operating profit margin of 20.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is IDEX Corporation's gross profit and gross margin?

IDEX Corporation (IEX) generated $1.54B in gross profit for the year, representing a gross profit margin of 44.5%. This demonstrates the company's core pricing power and production efficiency.